Investment
Features
FeesSafety
Academy
More
Pluang+

Trump rejects calls for AI regulation, defends US leadership against China in AI race

Market News
14 Sep 2026
CNBC
View Source
Bearish
Trump rejects calls for AI regulation, defends US leadership against China in AI race

President Donald Trump pushed back against increasing demands for stricter artificial intelligence regulation, criticizing Anthropic CEO Dario Amodei's call for an AI development slowdown. Trump claimed that strong leadership from the US president is sufficient to control AI risks and emphasized that the US already has significant regulatory power over AI companies. He framed the AI race as a critical competition with China, warning against conspiracies he believes undermine US progress. This stance highlights ongoing tensions in AI governance and international competition.

Donald Trump's stance on AI regulation comes as Pluang's Technology sector shows mixed performance. For readers following technology stocks, here is Pluang's market snapshot as of Sep 14, 2026 19:44 WIB: out of 150 priced US technology stocks, 67 rose and 77 fell. Notable movers include Teradyne, Inc. (TER) at USD 351.71 with a 7.41% decline, Applied Materials, Inc. (AMAT) at USD 422.92 down 7.35%, and Marathon Digital Holdings Inc (MARA) at USD 11.13 down 7.10%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App